The frequency of APOE ε4 in PART-NC is approximately 10%, while its prevalence in AD exceeds 45% (Frisoni 1998, Gharbi-Meliani 2021) A major genetic risk factor for PART-NC is the microtubule-associated protein tau (MAPT) gene. Here, MAPT is linked to Alzheimer disease.